Cat. No. Name Size Price Add Cart
KI0021U01261 mg$110
U01265 mg$198
U012610 mg$318
U012620 mg$500

Chemical Characteristic

Product NameU0126
CAS No.109511-58-2
Molecular Weight 380.49
FormulaC18H16N6S2
Chemical Name2,3-Bis[amino[(2-aminophenyl)thio]methylene]butanedinitrile
SmilesC(=C(\C(=C(\Sc1c(cccc1)N)/N)\C#N)/C#N)(/Sc1c(cccc1)N)\N
Chemical Structure

Biological activities

U0126 is a highly selective inhibitor of both MEK1 and MEK2 which are human extracellular signal-regulated kinase activator kinases. The IC50 of U0126 is 72 and 58 nM against MEK1 and MEK2, respectively. U0126 functionally antagonize AP-1(activator protein 1) transcriptional activity via noncompetitive inhibition of the dual specificity kinase MEK with IC50 of 72 nM for MEK1 and 58 nM for MEK2.[1] U0126 is a mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase inhibitor. U0126 reverses morphology and inhibits anchorage-independent growth of Ki-ras-transformed rat fibroblasts. U0126 suppresses activation of p70S6K, but not Akt, at concentrations at which it normalizes the transformed phenotypes.[2] U0126 exhibits a dose-dependent inhibition of A375 cell invasion through growth factor-reduced Matrigel. At 5 µM, U0126 inhibits phosphorylation of the MEK 1/2 to a non-detectable level within 24 hours. The phosphorylation of extracellular signal-related kinase 1/2 is also dramatically suppressed by the treatment with 10 µM U0126.[3] U0126 attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis. U0126 decreases ERK1/2 phosphorylation following cisplatin administration with significant functional and histologic protection. [4] U0126 dose-dependently blocks the basal phosphorylation of ERK. Renal phosphorylation of ERK is reduced, in a dose-dependent manner, in rats treated with U0126.[5]

Protocols

U0126 is dissolved in DMSO.[5]

References

[1] Casciani V, et al. Opposite effect of phorbol ester PMA on PTGS2 and PGDH mRNA expression in human chorion trophoblast cells. Reprod Sci. 2008, 15(1): 40-50.
[2] Fukazawa H, et al. U0126 reverses Ki-ras-mediated transformation by blocking both mitogen-activated protein kinase and p70 S6 kinase pathways. Cancer Res. 2000, 60(8): 2104-2107.
[3] Ge X, et al. U0126, a mitogen-activated protein kinase kinase inhibitor, inhibits the invasion of human A375 melanoma cells. Cancer Lett. 2002, 179(2): 133-140.
[4] Jo SK, et al. MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis. Kidney Int. 2005, 67(2): 458-466.
[5] Bokemeyer D, et al. In vivo identification of the mitogen-activated protein kinase cascade as a central pathogenic pathway in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol. 2002, 13(6): 1473-1480.

Please click here to fill online order form, and we will make sure to supply you product with detail information. This process usually takes between 24 to 48 hours, depending on products stock avaliability. All inquires and subsequent projects are handled in the strictest confidence and will be backed by a confidentiality agreement if required.
KareBayTM provides scientists and clinicians with a wide range of biotechnological products and science lab supplies for chemical research and analyzing life processes. KareBay's extensive capabilities include commercializing reagents and kits, manufacturing biotech products and providing contract research services to organizations worldwide. Our many global labs, offices, and business partners enable KareBay to extend its products and services to its customer base around the world.

Our products are used for research, laboratory and further evaluation purposes. They are not for human use.